Raymond James Increases Solazyme Price Target to $12.50 (SZYM)

Share on StockTwits

Solazyme (NASDAQ: SZYM) had its price target increased by Raymond James from $10.50 to $12.50 in a research report sent to investors on Monday morning, Stock Ratings Network.com reports. The firm currently has an outperform rating on the stock.

A number of other analysts have also recently weighed in on SZYM. Analysts at Robert W. Baird raised their price target on shares of Solazyme from $10.00 to $12.00 in a research note to investors on Friday, May 10th. They now have an outperform rating on the stock. Analysts at Morgan Stanley initiated coverage on shares of Solazyme in a research note to investors on Friday, April 19th. They set an overweight rating on the stock.

Nine equities research analysts have rated the stock with a buy rating, The stock presently has a consensus rating of Buy and an average price target of $12.63.

Shares of Solazyme (NASDAQ: SZYM) opened at 11.91 on Monday. Solazyme has a 52 week low of $6.45 and a 52 week high of $14.34. The stock’s 50-day moving average is currently $8.1. The company’s market cap is $736.4 million.

Solazyme, Inc. (NASDAQ: SZYM) makes oil.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Latest News

Xiaomi Sales of Smartphones Not So Disappointing
Xiaomi Sales of Smartphones Not So Disappointing
Celgene Investing $1 Billion in Juno Therapeutics
Celgene Investing $1 Billion in Juno Therapeutics
Greece Considering Capital Controls and Bank Closures
Greece Considering Capital Controls and Bank Closures
Nike Earnings Run Past Estimates
Nike Earnings Run Past Estimates
Ikea Raising Minimum Wage for U.S. Workers
Ikea Raising Minimum Wage for U.S. Workers
Facebook Catching YouTube in Ads for Videos
Facebook Catching YouTube in Ads for Videos


Advertisement
Advertisement
© 2006-2015 Ticker Report. Google+.